sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Tue Jun 2
Mon Jun 1
Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating
1d
Y
Evaluating Zoom’s (ZM) Event-Driven Trade
1d
Y
Is Fold Holdings, Inc. (FLD) Under Pressure After Revenue Drops 21% in Q1 2026?
1d
Y
Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?
1d
Y
TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss
1d
Y
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
1d
Y
Is Expensify, Inc. (EXFY) Strengthening Its Expense Ecosystem Through New VAT Reclaim Partnership?
1d
Y
Covenant (CVLG) Q1 2026 Earnings Transcript
1d
Y
GoPro, Inc. (GPRO) Stock Focus Shifts to Diversification Beyond Action Cameras
1d
Y
Target vs Walmart: Both Fighting For The Same Customer, Only One Wins
1d
Y
Business Owners: The One Tax Move Financial Advisors Say You Can’t Skip Before Year-End
1d
Y
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity
1d
Y
Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?
1d
Y
Is ESS Tech, Inc. (GWH) Still a Buy After Softer Q1 Results and Lower Price Target?
1d
Y
Is Kymera Therapeutics, Inc. (KYMR) a Long-Term Biotech Winner After New Buy Rating and Coverage Launch At Canaccord?
1d
Y
MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress
1d
Y
UBS Lifts Valuation On Moderna, Inc. (MRNA) Ahead of Key Pipeline Catalysts
1d
Y
Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?
1d
Y
Why Okta Is One of the Hottest AI-Driven Stocks to Buy Now
1d
Y
Cleveland Fed president warns rate hikes could be on the table 'if recent trends continue' with inflation
1d
Y
Core Scientific (CORZ): A Shovel-Ready Leader in the AI Tech Landscape
1d
Y
Dear Future Applied Aerospace & Defense Stock Investors, Mark Your Calendars for June 3
1d
Y
Hallador to buy Siemens turbines from EWC for $350m
1d
Y
FIBK Q4 2025 Earnings Transcript
1d
Y
FIBK Q1 2026 Earnings Transcript
1d
Y
Microsoft Stock Is Up Nearly 30% From Its March Lows, But You Shouldn’t Sell MSFT Just Yet
1d
Y
MRVL: Why is AI chipmaker Marvell’s stock price surging today? It comes down to 4 words from Nvidia’s Jensen Huang
1d
Y
Income Safe-Haven Under $40: Why This Packaging Giant’s 5.8% Yield Is Mispriced
1d
Y
Victoria’s Secret Shares Jump After Strong Quarterly Results and Upgraded Outlook (VSCO)
1d
Y
Elizabeth Warren Branded Kevin Warsh Trump’s ‘Sock Puppet.’ His First Fed Meeting May Prove Her Wrong
1d
Y
Belden (BDC) is Set to Benefit from Secular Tailwinds
1d
Y
CoreWeave Shares Advance Following BNP Paribas Upgrade and Ongoing AI Sector Strength (CRWV)
1d
Y
Why The AI Agentic Era Doesn't Justify A Premium For MongoDB Stock Just Yet
1d
Y
Shake Shack Shares Drop After Company Lowers 2026 Outlook (SHAK)
1d
Y
Should You Consider Selling Crocs (CROX)?
1d
Y
South Africa’s Tiger to sell chocolate brand Beacon
1d
Y
ChatGPT Says You Should Buy Amphenol (APH) – ‘A Cleaner Way to Ride AI CapEx’
1d
Y
Virgin Galactic Shares Slide After Debt Redemption Plan Involving New Stock Issuance (SPCE)
1d
Y
Is Mondelez International Stock Underperforming the Dow?
1d
Y
Cango (CANG) Q1 2026 Earnings Transcript
1d
Y
What Makes Barrett Business Services (BBSI) a Good Investment?
1d
Y
As Software M&A Heats Up, These 3 Acquisition Targets Are in the Spotlight
1d
Y
Is Airbnb Stock Underperforming the S&P 500?
1d
Y
Salesforce vs. ServiceNow: 1 AI Giant Is Leaving the Other Behind
1d
Y
Fortune Brands Innovations (FBIN) Gains from Favorable Demand Trends
1d
Y
Celestica Ready To Explode Higher - 2 Reasons
1d
S
Nvidia CEO Endorses Marvell As Next Trillion-Dollar Giant. Stock Jumps 29%.
1d
Y
SpaceX negotiating underwriting fees under 0.75% for IPO, Bloomberg News reports
1d
Y
MoneyGram Launches New Stablecoin
1d
Y
How Is Starbucks’ Stock Performance Compared to Other Consumer Discretionary Stocks?
1d
Y
More →